Skip to main content

Table 3 Univariate analysis for overall survival in lung cancer patients with malignant pleural effusion a

From: Elevated pleural effusion IL-17 is a diagnostic marker and outcome predictor in lung cancer patients

Parameters Patients ( n) OS (months) P-value
Age (years)    0.038*
  ≥60 38 5.1  
  <60 40 9.4  
Gender    0.538
  Male 36 8.7  
  Female 42 6.2  
IL-17 (pg/ml)    0.023*
  ≥15 26 4.7  
  <15 52 10.8  
ECOG PS    0.011*
  0 or 1 50 9.4  
  2 to 4 28 3.1  
Histologic type    0.617
  Adenocarcinoma 67 7.5  
  Nonadenocarcinoma 11 5.3  
Stage    0.047*
  M1a 54 8.6  
  M1b 24 4.2  
Location    0.636
  Right 50 7.3  
  Left 28 6.9  
  1. aECOG PS, Eastern Cooperative Oncology Group performance status; OS, overall survival. *Significant difference.